So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Đánh giá Tác động Phản thực tế của Hiệu ứng Điều trị Không đồng nhất× | Ghép cặp điểm xu hướng× | |
|---|---|---|
| Lĩnh vực≠ | Suy luận nhân quả | Thống kê nghiên cứu |
| Họ≠ | Regression model | Process / pipeline |
| Năm ra đời≠ | 2010s | 1983 |
| Người khởi xướng≠ | Cerulli (2010) for CIE framework; Athey & Wager (2019) for causal forest-based CATE within CIE | Paul Rosenbaum and Donald Rubin |
| Loại≠ | Quasi-experimental causal inference with subgroup heterogeneity | Method |
| Công trình gốc≠ | Cerulli, G. (2010). Modelling and measuring the effect of public subsidies on business R&D: A critical review of the econometric literature. Economic Record, 86(274), 421-449. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Tên gọi khác≠ | HTE-CIE, heterogeneous CIE, CATE-based counterfactual evaluation, subgroup counterfactual impact evaluation | PSM, propensity score weighting, covariate balance |
| Liên quan≠ | 4 | 3 |
| Tóm tắt≠ | Heterogeneous Treatment Effect Counterfactual Impact Evaluation (HTE-CIE) extends standard counterfactual impact evaluation by estimating how the causal effect of a policy or intervention varies across subgroups defined by pre-treatment characteristics. Rather than reporting a single average treatment effect, it maps the Conditional Average Treatment Effect (CATE) across the covariate space, revealing who benefits most or least from an intervention. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateBộ dữ liệu ↗ |
|
|